Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-21

Clinical Trial Update: A COMPARATIVE STUDY BETWEEN 1MG AND 3 MG OF GRANISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN STRABISMUS OPHTHALMIC SURGERIES DURING GENERAL ANESTHESIA [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 1 mg vs 3 mg granisetron for prevention of postoperative nausea and vomiting in strabismus ophthalmic surgery under general anesthesia (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Granisetron (granisetron)

Snippet

Sponsor: Cairo University | Conditions: 1mg Vs 3 mg of Granisetron | Phase 3 | Status: COMPLETED